Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Prieto

Showing results (631-640 of 657) with videos related to

Pageof 66
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic featuresPriyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancerDi Ai, Jun Yao, Fei Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group ReportHoward M Shulman, Diana M Cardona, Joel K Greenson, et al.
Cancer Research|September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Melanoma Research|May 12, 2009
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrenceKevin B Kim, Sewa S Legha, Rene Gonzalez, et al.
Annals of Surgical Oncology|March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
British Journal of Cancer|August 30, 2008
Phase II trial of imatinib mesylate in patients with metastatic melanomaK B Kim, O Eton, D W Davis, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Annals of Hepatology|January 21, 2026
Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research NetworkJhon E Prieto, Diego R Puentes, Angelo-Z Mattos, et al.
Pageof 66

Showing results (631-640 of 657) with videos related to

Sort By:
Pageof 66
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic featuresPriyadharsini Nagarajan, Jin Piao, Jing Ning, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancerDi Ai, Jun Yao, Fei Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group ReportHoward M Shulman, Diana M Cardona, Joel K Greenson, et al.
Cancer Research|September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Melanoma Research|May 12, 2009
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrenceKevin B Kim, Sewa S Legha, Rene Gonzalez, et al.
Annals of Surgical Oncology|March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.
British Journal of Cancer|August 30, 2008
Phase II trial of imatinib mesylate in patients with metastatic melanomaK B Kim, O Eton, D W Davis, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Annals of Hepatology|January 21, 2026
Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research NetworkJhon E Prieto, Diego R Puentes, Angelo-Z Mattos, et al.
Pageof 66